Page last updated: 2024-10-18

dalteparin and Cancer of Muscle

dalteparin has been researched along with Cancer of Muscle in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davutoglu, V1
Kervancioglu, S1
Sezen, Y1
Olsson, E1
Svartling, N1
Asko-Seljavaara, S1
Lassila, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial[NCT02548377]60 participants (Actual)Interventional2015-09-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for dalteparin and Cancer of Muscle

ArticleYear
Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer.
    Microsurgery, 2001, Volume: 21, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Coagulation; Bone Neoplasms; Dalteparin;

2001

Other Studies

1 other study available for dalteparin and Cancer of Muscle

ArticleYear
Large rectus muscle hematoma with intraperitoneal bleeding and fatal abdominal compartment syndrome complicating anticoagulant therapy.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2005, Volume: 11, Issue:1

    Topics: Anticoagulants; Compartment Syndromes; Enoxaparin; Fatal Outcome; Female; Hematoma; Hemorrhage; Huma

2005